Allerayde SAB, Inc.

Allerayde SAB, Inc.

November 04, 2013 14:54 ET

Allerayde SAB Retains Investor Communication Firm

LONDON, UNITED KINGDOM--(Marketwired - Nov. 4, 2013) - Allerayde SAB, Inc. (OTCQB:ASAB), with its subsidiary, Allerayde SAB Limited (the "Company") today announced that the Company has retained Morningstar Corporate Communication to handle its investor communication efforts.

The management team has been made aware that certain promotional materials that were distributed making various statement of the Company, its operation, valuation and stock. The Company wants to assure its shareholders and investors that it has no role in preparing or disseminating such promotional materials and it did not pay for them and was unaware of that these materials had been prepared.

About Allerayde SAB, Inc.:

Allerayde SAB, Inc. is engaged in the business of developing and manufacturing an innovative anaphylaxis pen product and other consumer health care products for allergy and eczema patients.

The Company's principal product is the AAAPen®. The AAAPen® is a new epinephrine/adrenaline pen for the emergency treatment of anaphylaxis, the severe allergic shock, which may be identified by various rapid onset symptoms following exposure to certain allergens-such as insect venoms, peanuts, seafood, latex, etc.- that have caused symptoms from different level reactions. When the first signs of anaphylaxis being experienced, the AAAPen® shall be used.

Allerayde is also engaged in developing and manufacturing products for the prevention and relief of allergy, asthma and eczema.

Allerayde SAB, Inc. trades on the Over the Counter Market with the ticker symbol ASAB. For more information about the company please visit our website at:

Forward-Looking Statements:

This press release contains certain "forward-looking" statements, as defined in the United States Private Securities Litigation Reform Act of 1995 that involve a number of risks and uncertainties. Statements, which are not historical facts, are forward-looking statements. The Company, through its management, makes forward-looking public statements concerning its expected future operations, performance and other developments. Such forward-looking statements are necessarily estimates reflecting the Company's best judgment based upon current information and involve a number of risks and uncertainties, and there can be no assurance that other factors will not affect the accuracy of such.

Forward-looking statements. It is impossible to identify all such factors, factors that could cause actual results to differ materially from those estimated by the Company. They include, but are not limited to, the Company's ability to develop operations, the Company's ability to consummate and complete an acquisition, the Company's access to future capital, the successful integration of acquired companies, government regulation, managing and maintaining growth, the effect of adverse publicity, litigation, competition, sales and other factors that may be identified from time to time in the Company's public announcements.

This press release is provided for information purposes only and is not intended to constitute an offer to sell or a solicitation of an offer to buy securities.

Contact Information